Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 30, 2023, titled "Sun Pharma acquires Disperzyme�� and Phlogam�� brands to strengthen its anti-inflammatory portfolio".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 30, 2023, titled "Sun Pharma acquires Disperzyme�� and Phlogam�� brands to strengthen its anti-inflammatory portfolio".